LumaMed ::: PsiScan, Connect2Derm | Special Skin Cancer Care

PsiScan™

PsiScan™ is an easy to use, non-invasive imager that captures wide field, high resolution digital images of cancer margins real-time during surgery. The images have a resolution similar to those produced by conventional pathology but with a higher degree of contrast between normal and cancer tissue. This resolution and contrast with real-time feedback gives a superior navigation ability to the surgeon that did not exist before.

PsiScan's application crosses a broad spectrum of cancers including breast, oral, head and neck, and skin cancers with a world wide market of greater than $1.5 Billion. Breast cancer affects nearly one out of eight American women during their lifetime, of whom 30 to 40 percent undergo multiple surgeries to remove malignant breast tissue. Skin cancer is the most common cancer in the world with one in every 5 people in the U.S being affected by it. Mohs surgery is considered to be the most effective treatment of skin cancer but here too, patients typically undergo more than 2 iterations to remove the cancer.

Similarly, head and neck cancer surgeries involve 5 iterations of excisions. Multiple iterations during a surgery or alternatively multiple surgeries only result in increased cost to the healthcare system, patient discomfort and reduced efficiency and aggravation to the physician. LumaMed aims to eliminate these unnecessary iterations or surgeries.

Testimonial

“LumaMed’s technology has the potential to greatly improve cancer treatment outcomes by allowing the physician to clearly visualize tumor margins not apparent to the naked eye during surgery. Following its immediate applications for skin cancer, this technology could potentially find application in many other settings of cancer surgery."

R. Rox Anderson, M.D, Wellman Labs, Massachussets General Hospital. For more information on Dr. Anderson, click here.